Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Franke

Showing results (561-570 of 593) with videos related to

Pageof 60
Sort By:
Global Change Biology|May 17, 2021
Large potential for crop production adaptation depends on available future varietiesFlorian Zabel, Christoph Müller, Joshua Elliott, et al.
Environmental Pollution (Barking, Essex : 1987)|June 5, 2023
Particulate matter, traffic-related air pollutants, and circulating C-reactive protein levels: The Multiethnic Cohort StudyMeera Sangaramoorthy, Juan Yang, Chiuchen Tseng, et al.
Annals of Hematology|November 9, 2002
Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemiaW K Hofmann, G Seipelt, S Langenhan, et al.
American Journal of Public Health|April 17, 2015
Biomarkers of tobacco smoke exposure in racial/ethnic groups at high risk for lung cancerPebbles Fagan, Eric T Moolchan, Pallav Pokhrel, et al.
The Lancet. Oncology|April 13, 2015
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trialJean-Yves Blay, Zsuzsanna Pápai, Anthony W Tolcher, et al.
Journal of Cancer Research and Clinical Oncology|August 10, 2005
Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)M Herold, A Schulze, D Niederwieser, et al.
Clinical and Translational Allergy|November 10, 2016
Standardization of double blind placebo controlled food challenge with soy within a multicentre trialR Treudler, A Franke, A Schmiedeknecht, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 7, 2012
Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trialSeema A Khan, Robert T Chatterton, Nancy Michel, et al.
Plos One|January 6, 2023
Genome-wide association study of abdominal MRI-measured visceral fat: The multiethnic cohort adiposity phenotype studySamantha A Streicher, Unhee Lim, S Lani Park, et al.
Nature Communications|January 5, 2024
Functional host-specific adaptation of the intestinal microbiome in hominidsM C Rühlemann, C Bang, J F Gogarten, et al.
Pageof 60

Showing results (561-570 of 593) with videos related to

Sort By:
Pageof 60
Global Change Biology|May 17, 2021
Large potential for crop production adaptation depends on available future varietiesFlorian Zabel, Christoph Müller, Joshua Elliott, et al.
Environmental Pollution (Barking, Essex : 1987)|June 5, 2023
Particulate matter, traffic-related air pollutants, and circulating C-reactive protein levels: The Multiethnic Cohort StudyMeera Sangaramoorthy, Juan Yang, Chiuchen Tseng, et al.
Annals of Hematology|November 9, 2002
Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemiaW K Hofmann, G Seipelt, S Langenhan, et al.
American Journal of Public Health|April 17, 2015
Biomarkers of tobacco smoke exposure in racial/ethnic groups at high risk for lung cancerPebbles Fagan, Eric T Moolchan, Pallav Pokhrel, et al.
The Lancet. Oncology|April 13, 2015
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trialJean-Yves Blay, Zsuzsanna Pápai, Anthony W Tolcher, et al.
Journal of Cancer Research and Clinical Oncology|August 10, 2005
Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)M Herold, A Schulze, D Niederwieser, et al.
Clinical and Translational Allergy|November 10, 2016
Standardization of double blind placebo controlled food challenge with soy within a multicentre trialR Treudler, A Franke, A Schmiedeknecht, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 7, 2012
Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trialSeema A Khan, Robert T Chatterton, Nancy Michel, et al.
Plos One|January 6, 2023
Genome-wide association study of abdominal MRI-measured visceral fat: The multiethnic cohort adiposity phenotype studySamantha A Streicher, Unhee Lim, S Lani Park, et al.
Nature Communications|January 5, 2024
Functional host-specific adaptation of the intestinal microbiome in hominidsM C Rühlemann, C Bang, J F Gogarten, et al.
Pageof 60